Jeffrey Weitz
We are delighted to learn that hematologist Jeffrey Weitz – a long-time research collaborator with PHRI – has been named an Officer of the Order of Canada.
The esteemed clinician-scientist plays a key role in PHRI’s program, STRIVE (Strategic Translational Research in Vascular Health (STRIVE) launched this time last year.
The program’s intention is to deepen and formalize the integration of clinical and population research done at PHRI with the fundamental research done at the Thrombosis and Atherosclerosis Research Institute (TaARI), of which Weitz is Director.
Weitz is a pivotal support to STRIVE program lead, Guillaume Paré, a PHRI Senior Scientist, Deputy Director at TaARI, and Director of the CRLB-GMEL (the lab and biobank in the same building that houses PHRI and TaARI).
Weitz and Paré have scientifically collaborated together at TaARI for many years now. What is new as of 2022 is the expanded scale and optimization of processes to ensure that biological pathways identified at TaARI are evaluated clinically by PHRI and, conversely, clinical findings emanating from PHRI are mechanistically investigated by TaARI.
Bestowed by Her Excellency The Right Honourable Mary Simon, Governor General of Canada, Weitz received the Order of Canada for “his outstanding contributions to the prevention, diagnosis and treatment of clotting disorders, and for his leadership in the fields of thrombosis and hemostasis.”
Weitz is the Immediate Past President of the International Society on Thrombosis and Haemostasis (ISTH), and a Professor of Medicine, and Associate Member of Biochemistry and Biomedical Sciences, at McMaster University.
Guillaume Pare (centre) is supported by Jeffrey Weitz and Hertzel Gerstein, PHRI Deputy Director, in the STRIVE translational research program.
